• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Editor's Pick

Pfizer appeals denial of $75 million claim in SEC case against Cohen hedge fund

by January 15, 2025
written by January 15, 2025

NEW YORK (Reuters) – Pfizer (NYSE:PFE) on Tuesday appealed a federal judge’s refusal to award the drugmaker $75.2 million from a more than decade-old insider trading settlement involving billionaire Steven A. Cohen’s former hedge fund, SAC Capital Management.

The money was left over from SAC’s $602 million settlement in March 2013 with the U.S. Securities and Exchange Commission over trades in drugmakers Wyeth and Elan by Mathew Martoma, who worked at an SAC unit and was later convicted.

Pfizer said it deserved the $75.2 million because a neurologist who tipped Martoma about a 2008 Alzheimer’s drug trial owed a fiduciary duty to Wyeth, which Pfizer bought in 2009, because he had been a consultant there.

U.S. District Judge Victor Marrero in Manhattan, however, ruled in November that Wyeth was not a victim of Martoma’s trading, and thus Pfizer was not entitled to funds left over after Wyeth and Elan investors who lost money were compensated.

Pfizer appealed Marrero’s decision to the 2nd U.S. Circuit Court of Appeals in Manhattan. The appeals process often takes several months or longer.

Cohen was not criminally charged. He changed SAC Capital’s name to Point72 Asset Management in 2014, and is now worth $21.3 billion according to Forbes magazine.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
Boeing delivered 30 airplanes in December, but gap with Airbus widened in 2024
next post
Japan manufacturers’ mood rebounds in Jan, outlook stays flat – Reuters Poll

You may also like

China central bank conducts 1.7 trln yuan of...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

ECB president fears loss of central bank independence

January 27, 2025

European tech shares tumble as China’s AI push...

January 27, 2025

Futures slip as investors eye China’s latest AI...

January 27, 2025

Markets may be repeating the mistake of 2019,...

January 27, 2025

How billionaire Caltagirone could influence Italy’s banking M&A...

January 27, 2025

How Italy’s MPS went from near collapse to...

January 27, 2025

Analysis-To weather Trump, emerging market investors look to...

January 27, 2025

Chinese AI startup DeepSeek overtakes ChatGPT on Apple...

January 27, 2025
Fill Out & Get More Relevant News








    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • Procter & Gamble to cut 7,000 jobs as part of broader restructuring

      June 6, 2025
    • Shein and Temu see U.S. demand plunge as loophole for cheap goods closes

      June 6, 2025
    • Shein and Temu see U.S. demand plunge as loophole for cheap goods closes

      June 5, 2025
    • This California startup is cleaning water and removing CO₂ from the atmosphere — all at a reduced cost

      June 5, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (504)
    • Stock (6,426)

    Latest News

    • Procter & Gamble to cut 7,000 jobs as part of broader restructuring
    • Shein and Temu see U.S. demand plunge as loophole for cheap goods closes

    Popular News

    • Stellantis swiftly reshapes strategy under Elkann after Tavares exit
    • Dollar Tree beats sales and profit estimates, CFO to step down

    About The Significant deals

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy